2013•Journal of Wenzhou Medical CollegeRequires access

Expression of recombinant eukaryotic vector in 293 cell

Huang Qiongfang

Open publisher page 0 citations

Abstract

Objective: To investigate plasmid pSecTag2HygroC/CD13-1/RFP transfected into 293 cells by lipofectamine 2000.Methods: The plasmid pSecTag2HygroC/CD13-1/RFP was transfected into 293 cells by lipofectamine 2000,then determined by RFP fluorescence.The culture fuild of transfected 293 cells was collected and concentrated.The embranin and plasmosin of transfected 293 cells were extracted to verify whether the transfection cells could express the interest protein using Western blot.Results: ① The expression of RFP in 293 cell was observed under fluorescence microscopy.② The result of Western blot showed that the plasmosin of transfected 293 cells(about 62kDa) was expressed stably.Conclusion: Through cell transfection with lipofectamine 2000,plasmid pSecTag2HygroC/CD13-1/RFP can be transfected successfully into 293 cells,which would be a firm foundation for further studies on this monoclonal antibodie applied in clinical therapy.

About this research paper

What this paper is about

Objective: To investigate plasmid pSecTag2HygroC/CD13-1/RFP transfected into 293 cells by lipofectamine 2000.Methods: The plasmid pSecTag2HygroC/CD13-1/RFP was transfected into 293 cells by lipofectamine 2000,then determined by RFP fluorescence.The culture fuild of transfected 293 cells was collected and concentrated.The embranin and plasmosin of transfected 293 cells were extracted to verify whether the transfection cells could express the interest protein using Western blot.Results: ① The expression of RFP in 293 cell was observed under fluorescence microscopy.② The result of Western blot showed that the plasmosin of transfected 293 cells(about 62kDa) was expressed stably.Conclusion: Through cell transfection with lipofectamine 2000,plasmid pSecTag2HygroC/CD13-1/RFP can be transfected successfully into 293 cells,which would be a firm foundation for further studies on this monoclonal antibodie applied in clinical therapy.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective: To investigate plasmid pSecTag2HygroC/CD13-1/RFP transfected into 293 cells by lipofectamine 2000.Methods: The plasmid pSecTag2HygroC/CD13-1/RFP was transfected into 293 cells by lipofectamine 2000,then determined by RFP fluorescence.The culture fuild of transfected 293 cells was collected and concentrated.The embranin and plasmosin of transfected 293 cells were extracted to verify whether the transfection cells could express the interest protein using Western blot.Results: ① The expression of RFP in 293 cell was observed under fluorescence microscopy.② The result of Western blot showed that the plasmosin of transfected 293 cells(about 62kDa) was expressed stably.Conclusion: Through cell transfection with lipofectamine 2000,plasmid pSecTag2HygroC/CD13-1/RFP can be transfected successfully into 293 cells,which would be a firm foundation for further studies on this monoclonal antibodie applied in clinical therapy.

Key concepts: Lipofectamine, Transfection, Molecular biology, Plasmid, HEK 293 cells, Western blot, Cell culture, Recombinant DNA

Related papers

Back to paper searchBrowse research topicsOriginal source
Expression of recombinant eukaryotic vector in 293 cell — Research Paper | ScholarLens